Alemtuzumab (Lemtrada) and Amikacin liposome Inhalation
Determining the interaction of Alemtuzumab (Lemtrada) and Amikacin liposome Inhalation and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: alemtuzumab
Brand name: Campath, Lemtrada
Synonyms: Alemtuzumab
Generic Name: amikacin liposome
Brand name: Arikayce
Synonyms: Amikacin liposome, Amikacin (Oral Inhalation)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Alemtuzumab (Lemtrada)-Amikacin Sulfate
- Alemtuzumab (Lemtrada)-Amikin
- Alemtuzumab (Lemtrada)-Amikin Pediatric
- Alemtuzumab (Lemtrada)-Amiloride
- Alemtuzumab (Lemtrada)-Amiloride and Hydrochlorothiazide
- Alemtuzumab (Lemtrada)-Amiloride Hydrochloride
- Amikacin liposome Inhalation-Alemtuzumab Intravenous
- Amikacin liposome Inhalation-Alenaze-D
- Amikacin liposome Inhalation-Alendronate
- Amikacin liposome Inhalation-Alendronate and cholecalciferol
- Amikacin liposome Inhalation-Alendronate Effervescent Tablets
- Amikacin liposome Inhalation-Alendronate Oral Solution